Drug Products
The following products are approved, filed, or ready for filing in the US. We are seeking marketing partners or licensing opportunities for global markets.
Generic Drug Products
(ANDA, 505b2 NDA)
Linagliptin 5mg Tablet
Sevoflurane 250mL Bottle
Paclitaxel Protein-Bound, 100mg/Vial Powder
Biosimilars
Aflibercept (40mg/mL) Vial
Adalimumab (20mg/0.4mL, 40mg/0.8mL) PFS
Albipagrastim Alfa
Bevacizumab (100mg/4ml, 400mg/16mL) Vial
Bevifibatide Citrate (20mg/10mL) Vial
Denosumab (60mg/1mL) PFS
Denosumab (120mg/1.7mL) Vial
Golimumab
Tocilizumab (80mg/4mL, 200mg/10mL, 400mg/20mL) Vial
Trastuzumab (150mg) Powder